TY - JOUR
T1 - Is MED13L-related intellectual disability a recognizable syndrome?
AU - Tørring, Pernille Mathiesen
AU - Larsen, Martin Jakob
AU - Brasch-Andersen, Charlotte
AU - Krogh, Lotte Nylandsted
AU - Kibæk, Maria
AU - Laulund, Lone
AU - Illum, Niels
AU - Dunkhase-Heinl, Ulrike
AU - Wiesener, Antje
AU - Popp, Bernt
AU - Marangi, Giuseppe
AU - Hjortshøj, Tina Duelund
AU - Ek, Jakob
AU - Vogel, Ida
AU - Becher, Naja
AU - Roos, Laura
AU - Zollino, Marcella
AU - Fagerberg, Christina Ringmann
PY - 2019/2
Y1 - 2019/2
N2 - Introduction: MED13L-related intellectual disability is characterized by moderate intellectual disability (ID), speech impairment, and dysmorphic facial features. We present 8 patients with MED13L-related intellectual disability and review the literature for phenotypical and genetic aspects of previously described patients. Materials and methods: In the search for genetic aberrations in individuals with ID, two of the patients were identified by chromosomal microarray analysis, and five by exome sequencing. One of the individuals, suspected of MED13L-related intellectual disability, based on clinical features, was identified by Sanger sequencing. Results: All 8 individuals had de novo MED13L aberrations, including two intragenic microdeletions, two frameshift, three nonsense variants, and one missense variant. Phenotypically, they all had intellectual disability, speech and motor delay, and features of the mouth (open mouth appearance, macroglossia, and/or macrostomia). Two individuals were diagnosed with autism, and one had autistic features. One had complex congenital heart defect, and one had persistent foramen ovale. The literature was reviewed with respect to clinical and dysmorphic features, and genetic aberrations. Conclusions: Even if most clinical features of MED13L-related intellectual disability are rather non-specific, the syndrome may be suspected in some individuals based on the association of developmental delay, speech impairment, bulbous nasal tip, and macroglossia, macrostomia, or open mouth appearance.
AB - Introduction: MED13L-related intellectual disability is characterized by moderate intellectual disability (ID), speech impairment, and dysmorphic facial features. We present 8 patients with MED13L-related intellectual disability and review the literature for phenotypical and genetic aspects of previously described patients. Materials and methods: In the search for genetic aberrations in individuals with ID, two of the patients were identified by chromosomal microarray analysis, and five by exome sequencing. One of the individuals, suspected of MED13L-related intellectual disability, based on clinical features, was identified by Sanger sequencing. Results: All 8 individuals had de novo MED13L aberrations, including two intragenic microdeletions, two frameshift, three nonsense variants, and one missense variant. Phenotypically, they all had intellectual disability, speech and motor delay, and features of the mouth (open mouth appearance, macroglossia, and/or macrostomia). Two individuals were diagnosed with autism, and one had autistic features. One had complex congenital heart defect, and one had persistent foramen ovale. The literature was reviewed with respect to clinical and dysmorphic features, and genetic aberrations. Conclusions: Even if most clinical features of MED13L-related intellectual disability are rather non-specific, the syndrome may be suspected in some individuals based on the association of developmental delay, speech impairment, bulbous nasal tip, and macroglossia, macrostomia, or open mouth appearance.
KW - Developmental delay
KW - Intellectual disability
KW - MED13L
KW - MED13L haploinsufficiency syndrome
KW - MED13L-related intellectual disability
U2 - 10.1016/j.ejmg.2018.06.014
DO - 10.1016/j.ejmg.2018.06.014
M3 - Journal article
C2 - 29959045
AN - SCOPUS:85049303965
SN - 1769-7212
VL - 62
SP - 129
EP - 136
JO - European Journal of Medical Genetics
JF - European Journal of Medical Genetics
IS - 2
ER -